Back to Program | 2010 Program and Abstracts Overview | 2010 Posters
Risk of Obesity-Related Cancer After Obesity Surgery in a Population-Based Cohort Study
Magdalena Plecka ÖStlund*, Jesper Lagergren, Yunxia Lu
Dept. of Molecular Medicine and Surgery, Karolinska Institute, Upper Gastrointestinal Research, Stockholm, Sweden
Objective: Obesity increases risk of several cancers, but it is uncertain whether weight reduction is followed by any decreased risk. To address this topic, we selected a group of patients representing a substantial weight loss starting at a defined time, i.e. patients submitted to obesity surgery. We hypothesized that risk of obesity-related cancer decreases with time after obesity surgery.Design and setting: A nationwide, population-based cohort study of obesity surgery in 1980-2006 registered in the Swedish Patient Register. New cancers were identified through the Swedish Cancer Register. Cohort members’ observed total number of overall obesity-related cancers and groups of obesity-related cancer (breast, prostate, colorectal, endometrial, kidney) were divided by the expected numbers, representing the baseline risk, thus calculating standardized incidence ratios (SIRs) with 95% confidence intervals (CIs). Time trends of SIR after obesity surgery were the main outcome measure. Results: Among a total of 13,123 obesity surgery patients, contributing with 125,049 person-years of follow-up, 296 new cases of obesity-related cancer were identified. There was no overall decrease in SIR of obesity-related cancer with increased time after obesity surgery (p for trend 0.40). Similarly, no statistically significant trends with follow-up time were found for cancer of the breast (p=0.60), prostate (p=0.34), endometrium (p=0.83), or kidney (p=0.42), while the risk of colorectal cancer increased with time (p for trend 0.01) after obesity surgery. Conclusions: The weight reduction following obesity surgery might not be entailed by a decreased risk of obesity-related cancer with increasing follow-up time as compared to the baseline risk.
Relative cancer risk, SIR (95% CI)
Years after surgery | All | Breast cancer | Prostate cancer | Colorectal cancer | Endometrial cancer | Kidney cancer |
1-4 | 1.0 (0.7- 1.2) | 0.5 (0.3- 0.8) | 1.2 (0.4- 2.9) | 0.7 (0.1- 1.9) | 2.1 (1.0- 3.7) | 2.9 (1.1-6.3) |
5-9 | 1.0 (0.8- 1.2) | 0.4 (0.3- 0.7) | 0.8 (0.3- 1.7) | 1.4 (0.7- 2.6) | 2.3 (1.4- 3.7) | 2.5 (1.0- 5.2) |
≥10 | 1.1 (0.9- 1.3) | 0.6 (0.4- 0.8) | 0.7 (0.3- 1.3) | 2.1 (1.3- 3.2) | 2.1 (1.4-3.2) | 3.7 (1.5- 5.5) |
P for trend | 0.40 | 0.60 | 0.34 | 0.01 | 0.83 | 0.42 |
Back to Program | 2010 Program and Abstracts Overview | 2010 Posters